Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Equity Ratio (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Equity Ratio for 16 consecutive years, with 0.66 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 23.18% to 0.66 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.66 through Dec 2025, up 23.18% year-over-year, with the annual reading at 0.66 for FY2025, 23.18% up from the prior year.
  • Equity Ratio hit 0.66 in Q4 2025 for Ironwood Pharmaceuticals, up from 0.67 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.61 in Q1 2023 to a low of 1.02 in Q1 2025.
  • Historically, Equity Ratio has averaged 0.19 across 5 years, with a median of 0.6 in 2023.
  • Biggest five-year swings in Equity Ratio: soared 4380.41% in 2021 and later plummeted 224.01% in 2023.
  • Year by year, Equity Ratio stood at 0.54 in 2021, then grew by 10.25% to 0.59 in 2022, then tumbled by 224.01% to 0.74 in 2023, then dropped by 16.81% to 0.86 in 2024, then rose by 23.18% to 0.66 in 2025.
  • Business Quant data shows Equity Ratio for IRWD at 0.66 in Q4 2025, 0.67 in Q3 2025, and 0.9 in Q2 2025.